Latest News

GeoVax Reports on Vaccine Development Progress
Expanding Pipeline for MVA-VLP Vaccine Platform Includes HIV, Zika, Ebola, Malaria, Hepatitis B and...
Continue Reading...
GeoVax Reports 2016 Year-End Financial Results
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines using ...
Continue Reading...
GeoVax Reports Promising Results for Zika Vaccine
100% Protection Observed in Lethal Preliminary Challenge Model GeoVax Labs, Inc. (OTCQB: GOVX), a b...
Continue Reading...